Income Statement (TTM)
Tonix Pharmaceuticals Holding Corp. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 8 | 10 | 12 | 11 | 10 | 10 | 10 |
| Change (%) | 94.74 | 31.95 | 21.54 | -9.37 | -10.60 | -0.53 | -2.09 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 5 | 6 | 10 | 9 | 8 | 7 | 7 |
| Change (%) | 99.71 | 35.01 | 52.60 | -8.38 | -13.23 | -9.23 | -1.35 | |
| % of Revenue | 59.51 | 61.03 | 62.45 | 78.41 | 79.26 | 76.93 | 70.19 | 70.73 |
| Gross Operating Profit | 2 | 3 | 4 | 3 | 2 | 2 | 3 | 3 |
| Change (%) | 87.43 | 27.16 | -30.11 | -12.94 | -0.56 | 28.51 | -3.84 | |
| % of Revenue | 40.49 | 38.97 | 37.55 | 21.59 | 20.74 | 23.07 | 29.81 | 29.27 |
| SG&A | 31 | 35 | 37 | 37 | 36 | 40 | 41 | 50 |
| Change (%) | 11.44 | 5.52 | 1.30 | -2.71 | 10.96 | 1.98 | 21.27 | |
| % of Revenue | 781.77 | 447.37 | 357.77 | 298.18 | 320.08 | 397.28 | 407.28 | 504.48 |
| R&D | 94 | 87 | 73 | 61 | 49 | 40 | 35 | 36 |
| Change (%) | -8.02 | -15.75 | -16.82 | -19.65 | -18.08 | -13.58 | 3.25 | |
| % of Revenue | 2,361.72 | 1,115.54 | 712.26 | 487.47 | 432.16 | 396.00 | 344.04 | 362.80 |
| OpEx | 128 | 126 | 116 | 108 | 94 | 88 | 82 | 92 |
| Change (%) | -1.27 | -7.98 | -7.27 | -12.78 | -6.44 | -6.09 | 11.79 | |
| % of Revenue | 3,203.01 | 1,623.94 | 1,132.48 | 864.06 | 831.49 | 870.20 | 821.51 | 938.00 |
| Operating Income | -124 | -118 | -106 | -95 | -83 | -78 | -72 | -82 |
| Change (%) | -4.36 | -10.60 | -10.06 | -13.23 | -5.87 | -6.81 | 13.72 | |
| % of Revenue | -3,103.01 | -1,523.94 | -1,032.48 | -764.06 | -731.49 | -770.20 | -721.51 | -838.00 |
| Interest Expense | -1 | |||||||
| Change (%) | ||||||||
| % of Revenue | -20.68 | |||||||
| Net Income | -121 | -117 | -99 | -149 | -135 | -130 | -132 | -81 |
| Change (%) | -3.60 | -15.49 | 51.14 | -9.24 | -3.86 | 1.45 | -38.28 | |
| % of Revenue | -3,033.74 | -1,501.78 | -961.87 | -1,196.11 | -1,197.86 | -1,288.25 | -1,313.87 | -828.22 |
Source: Capital IQ
